William Oh, Director of Precision Medicine at Yale Cancer Center, shared a post on LinkedIn:
“I gave Grand Rounds at Yale Cancer Center today outlining the past, present and future of cancer precision medicine (PM).
My conclusions?
- PM improves outcomes,
- We have a long way to go to implement PM widely
- The next generation of PM will incorporate new tests and tools, including AI.”
Other articles featuring William Oh on OncoDaily.